Zentalis Pharmaceuticals, Inc. (ZNTL)

Zentalis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	37.6	33.9	28.04	43.07	59.71	54.95
Short-Term Investments	265.83	337.18	454.88	394.3	280.17	283.55
Cash & Short-Term Investments	303.43	371.08	482.92	437.37	339.89	338.51
Cash Growth	-28.84%	-23.16%	10.41%	28.68%	0.41%	403.38%
Accounts Receivable	-	5	-	-	-	-
Other Receivables	-	-	-	-	-	0.42
Receivables	-	5	-	-	-	0.42
Prepaid Expenses	8.17	9.98	13.8	14.56	10.64	6.18
Restricted Cash	-	-	-	-	0.24	-
Total Current Assets	311.6	386.07	496.72	451.93	350.77	345.1
Property, Plant & Equipment	34.26	37.23	41.74	50.08	52.84	3.62
Long-Term Investments	-	-	-	21.21	37.5	-
Goodwill	-	-	3.74	3.74	3.74	3.74
Other Intangible Assets	-	-	-	-	-	8.8
Other Long-Term Assets	5.85	7.04	9.5	12.35	9.67	4.3
Total Assets	351.71	430.34	551.69	539.31	454.51	365.56
Accounts Payable	3.72	7.44	14.93	11.25	11.59	8.66
Accrued Expenses	31.68	42.22	51.54	42.85	29.93	18.63
Current Portion of Leases	3.63	3.07	2.62	2.16	1.45	0.9
Current Income Taxes Payable	-	-	0.28	0.38	0.97	0.41
Total Current Liabilities	39.02	52.73	69.37	56.65	43.94	28.6
Long-Term Leases	37.69	39.58	43.15	45.17	44.46	1.1
Long-Term Deferred Tax Liabilities	-	-	-	0.85	1.62	2.48
Other Long-Term Liabilities	0.5	0.85	1.78	2.62	-	-
Total Liabilities	77.21	93.15	114.3	105.29	90.03	32.18
Common Stock	0.07	0.07	0.07	0.06	0.05	0.04
Additional Paid-In Capital	1,404	1,391	1,324	1,031	723.59	509.34
Retained Earnings	-1,130	-1,054	-888.56	-596.37	-359.56	-200.83
Comprehensive Income & Other	0.06	0.56	2.19	-1.35	-0.13	0.04
Total Common Equity	274.5	337.19	437.28	433.8	363.95	308.58
Minority Interest	-	-	0.11	0.22	0.53	24.8
Shareholders' Equity	274.5	337.19	437.39	434.02	364.48	333.38
Total Liabilities & Equity	351.71	430.34	551.69	539.31	454.51	365.56
Total Debt	41.32	42.65	45.77	47.33	45.91	2
Net Cash (Debt)	262.11	328.44	437.15	390.04	293.98	336.51
Net Cash Growth	-31.45%	-24.87%	12.08%	32.68%	-12.64%	406.29%
Net Cash Per Share	3.67	4.62	6.68	7.38	6.89	11.97
Filing Date Shares Outstanding	72.14	71.81	70.96	59.42	45.56	41.04
Total Common Shares Outstanding	72.14	71.28	70.77	59.28	45.49	41.04
Working Capital	272.57	333.34	427.35	395.29	306.83	316.5
Book Value Per Share	3.81	4.73	6.18	7.32	8.00	7.52
Tangible Book Value	274.5	337.19	433.55	430.07	360.22	296.05
Tangible Book Value Per Share	3.81	4.73	6.13	7.25	7.92	7.21
Machinery	1.42	4.81	4.56	4.84	4.39	0.95
Construction In Progress	-	-	0.17	0.04	0.03	0.35
Leasehold Improvements	4.17	4.17	4.24	4.89	4.52	0.05

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q